Novartis has announced plans to expand its community health initiatives from 11 to over 30 countries by 2030, targeting underserved populations with heart disease and cancer. The expansion encompasses three distinct program types designed to close access gaps in diagnosis and treatment.
The company is launching Inclusive Health Accelerators across five U.S. cities – New York, Los Angeles, Detroit, Houston, and Baltimore – focused on improving access to breast and prostate cancer care through awareness, screening, and referral facilitation. Separately, Community Health Initiatives currently operating in Vietnam, Rwanda, and Bolivia will expand to at least 10 low- and middle-income countries for accelerated heart disease and cancer diagnosis.
The third pillar, CARDIO4Cities, is a data-driven cardiovascular health program currently operational in eight countries that has demonstrated three- to six-fold increases in hypertension control with associated reductions in cardiovascular events. That program is targeting expansion to 23 countries by 2030, making it the broadest of the three initiatives in geographic reach.